KRRO - Korro Bio, Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

382M

Cash

138.8M

Avg Qtr Burn

-17.37M

Short % of Float

6.95%

Insider Ownership

6.50%

Institutional Own.

84.67%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
KRRO-110 Details Alpha-1 Antitrypsin Deficiency	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
FX-322 Details Ear disease, Sensorineural hearing loss	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
FX-345 Details Sensorineural hearing loss, Ear disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.